Updates from FDA

The use of α2-adrenergic agonists (A2As), like guanfacine and clonidine, in preschool-aged children with ADHD has been on the rise, even though little data support safety and effectiveness for these medications in this patient population.

Clarissa Chan, PharmD

Use of fluticasone furoate nasal spray on an as-needed basis for patients with moderate-to-severe, persistent perennial allergic rhinitis yielded similar improvements in nasal symptoms compared with scheduled once daily use, according to findings of a recent randomized controlled trial.

Maria G. Tanzi, PharmD

Results of a new pragmatic trial called ADAPTABLE will give clinicians and their patients with heart disease more to discuss when it comes to the right dose of aspirin needed to prevent another heart attack or stroke.

Loren Bonner

Among the many collateral effects of COVID-19, the pandemic has exacerbated the mental health crisis in the United States. For some, the global shutdown interrupted ongoing mental health care. For others, the stress and isolation triggered new mental health issues.

Sonya Collins